"Accelerated phase" chronic lymphocytic leukemia: Still an intermediate risk disease in the era of targeted therapies. Issue 4 (8th March 2022)

• Record Type: Journal Article
• Authors: Lapierre, Léopoldine; Syrykh, Charlotte; Largeaud, Laetitia; Cabarrou, Bastien; Filleron, Thomas; Oberic, Lucie; Kanoun, Salim; Coster, Lucie; Laurent, Camille; Branco, Benoît; Gadaud, Noémie; Récher, Christian; Brechemier, Delphine; Balardy, Laurent; Vergez, François; Ysebaert, Loïc; Gauthier, Martin
• Is Part Of: Hematological oncology. Volume 40:Issue 4(2022)
• Page Start: 805
• Page End: 808
• Publication Date: 2022-03-08
• Subjects: accelerated phase -- BCL2 inhibitor -- chronic lymphocytic leukemia -- targeted therapies; Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.2985
• Languages: English
• ISSNs: 0278-0232